Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Treasury Shares (2023 - 2025)

Profound Medical has reported Treasury Shares over the past 3 years, most recently at $859335.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $859335.0 for Q4 2025, up 837.42% from a year ago — trailing twelve months through Dec 2025 was $859335.0 (up 837.42% YoY), and the annual figure for FY2025 was $859335.0, up 837.42%.
  • Treasury Shares for Q4 2025 was $859335.0 at Profound Medical, up from $143820.0 in the prior quarter.
  • Over the last five years, Treasury Shares for PROF hit a ceiling of $1.1 million in Q2 2025 and a floor of $91670.0 in Q4 2024.
  • Median Treasury Shares over the past 3 years was $516175.0 (2023), compared with a mean of $533771.5.
  • Biggest five-year swings in Treasury Shares: tumbled 81.42% in 2024 and later skyrocketed 837.42% in 2025.
  • Profound Medical's Treasury Shares stood at $493396.0 in 2023, then tumbled by 81.42% to $91670.0 in 2024, then skyrocketed by 837.42% to $859335.0 in 2025.
  • The last three reported values for Treasury Shares were $859335.0 (Q4 2025), $143820.0 (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.